Pharmaceuticals and Government Policy (Volume 26.3)

Main articles on pharamaceutcal and healthcare policy and consumer choice

Special Offer. Normal Price £7.50, Special Price £5.00

The main articles are on pharmaceuticals and health policy, guest edited by health policy expert Tony Hockley. The authors propose that, contrary to current trends in the UK, consumers of pharmaceuticals should be empowered to take their own decisions wherever it is feasible. Other articles by Charles Blankart and Achim Klaiber on public debt crises, John Considine on Yes Minister, Gisela Stuart on why we need another Ludwig Erhard, Benedikt Koehler on audit market reform. Plus columns and reviews.

Contents

Main Articles

Pharmaceuticals and government policy by Tony Hockley
A new role for consumers' preferences in the provision of healthcare by Harry Telser and Peter Zweifel
The long-term economic gain from new models of healthcare provision: the opportunities for pharmaceutical companies by Nick Bosanquet
Equity of access to innovative medicines: mission impossible? by Jim Attridge
Direct-to-consumer advertising (DTCA) of pharmaceuticals: an updated review of the literature and debate since 2003 by Frank Auton
Six issues in pharmaceuticals by Andrew Lilico
The state giveth, the state taketh away: supporting the research-based pharmaceutical industry in Europe and the UK by Mike Sedgley

Other Articles

Subnational government organisation and public debt crises by Charles B. Blankart and Achim Klaiber

"Yes Minister": invaluable material for teaching the public choice of bureaucracy/i] by John ConsidineEconomic ViewpointsThe European Union and economic decline: why we need another Ludwig Erhard by Gisela StuartAudit market failure by Benedikt KoehlerThe great contraction by W. Spencer KocherGordon Brown counts dead children: the true impact of inheritance tax by Cliff PrattenColumnsEnergy prices, inflation and monetary policy by Tim CongdonSceptics and the Washington consensus by Razeen SallyFree to choose: yes, Prime Minister/i] by James StanfieldSick at the world bank by Roger BateIn the NHS, more can mean less by John MeadowcroftBook Reviews

Invest in the IEA. We are the catalyst for changing consensus and influencing public debate.

Donate now

Thank you for